HomeFUNDINGKAHTNU Surgical Receives $2M Funding: To Expand Worldwide Sales

KAHTNU Surgical Receives $2M Funding: To Expand Worldwide Sales

July 15, 2020

KAHTNU Surgical, a U.S. medical technology company based in Alaska, announced today it had completed a $2.15 million Series A round of financing led by Kinetic Medical Co., Ltd. The investment will help KAHTNU Surgical aggressively expand worldwide sales and marketing efforts as well as broaden and accelerate product development for spine and orthopedic surgeons.

KAHTNU Surgical provides a range of products for spine and orthopedic surgery. Most notably KAHTNU Surgical provides the KASILOF Cervical Plate, CHENA-C PEEK Spacer and TALKEETNA Pedicle Screw systems for spine surgery. “This funding will accelerate the company’s ability to establish quality sales channels in the U.S. and aggressively expand our product development capabilities,” says Craig Wilcox, President and CEO. “KAHTNU Surgical is committed to product development that harnesses existing and emerging technologies to improve outcomes for spine and orthopedic surgeons and their patients,” notes Wilcox.

KAHTNU Surgical also announced a partnership with United Kingdom-based Ortho Consulting Group Ltd (OCG) to establish and support KAHTNU Surgical sales channels outside the United States. “Ortho Consulting Group’s team of industry experts brings a broad array of capabilities to KAHTNU, driving our European, and Outside U.S. KOL selection process, marketing, sales, distribution, training, logistics and operations. We are delighted to partner with OCG,” says Wilcox.

Andrew Dubowski, Ortho Consulting Group Commercial Director, adds: “We are thrilled to partner with KAHTNU Surgical. The commitment they show to provide high quality/cost-effective products in the spine industry makes this an exciting addition to our client portfolio. We are looking forward to helping KAHTNU Surgical grow globally.” More information on Ortho Consulting Group is at Orthocg.com.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy